Selected research
Market Structure
Global Milk Coagulants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Milk Coagulants market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Milk Coagulants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Milk Coagulants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Milk Coagulants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Milk Coagulants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Milk Coagulants include DuPont, Chr. Hansen Holding A/S, Enzyme Supplies Limited, Koninklijke DSM N.V., WalcoRen,, Fonterra Co-operative Group, Clarion Casein Ltd., Renco and Mahaan Foods Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Milk Coagulants market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Milk Coagulants and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Milk Coagulants sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Milk Coagulants market size, projected growth trends, production technologies, key applications, and end-use industries.
Milk Coagulants Segment by Company
DuPont
Chr. Hansen Holding A/S
Enzyme Supplies Limited
Koninklijke DSM N.V.
WalcoRen,
Fonterra Co-operative Group
Clarion Casein Ltd.
Renco
Mahaan Foods Ltd
AlindaVelco S.A.
Milk Coagulants Segment by Type
Liquid
Powder
Tablets
Milk Coagulants Segment by Application
Cheese
Dessert
Yogurt
Others
Milk Coagulants Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Milk Coagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Milk Coagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Milk Coagulants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Milk Coagulants market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Milk Coagulants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Milk Coagulants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Milk Coagulants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid
- Powder
- Tablets
Applications
- Cheese
- Dessert
- Yogurt
- Others
Companies covered
- DuPont
- Chr. Hansen Holding A/S
- Enzyme Supplies Limited
- Koninklijke DSM N.V.
- WalcoRen,
- Fonterra Co-operative Group
- Clarion Casein Ltd.
- Renco
- Mahaan Foods Ltd
- AlindaVelco S.A.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Milk Coagulants Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Milk Coagulants Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Milk Coagulants Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Milk Coagulants Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Milk Coagulants Market Dynamics
- 2.1 Milk Coagulants Industry Trends
- 2.2 Milk Coagulants Industry Drivers
- 2.3 Milk Coagulants Industry Opportunities and Challenges
- 2.4 Milk Coagulants Industry Restraints
3 Milk Coagulants Market by Manufacturers
- 3.1 Global Milk Coagulants Revenue by Manufacturers (2021-2026)
- 3.2 Global Milk Coagulants Sales by Manufacturers (2021-2026)
- 3.3 Global Milk Coagulants Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Milk Coagulants Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Milk Coagulants Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Milk Coagulants Manufacturers, Product Type & Application
- 3.7 Global Milk Coagulants Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Milk Coagulants Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Milk Coagulants Players Market Share by Revenue in 2025
- 3.8.3 2025 Milk Coagulants Tier 1, Tier 2, and Tier 3
4 Milk Coagulants Market by Type
- 4.1 Milk Coagulants Type Introduction
- 4.1.1 Liquid
- 4.1.2 Powder
- 4.1.3 Tablets
- 4.2 Global Milk Coagulants Sales by Type
- 4.2.1 Global Milk Coagulants Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Milk Coagulants Sales by Type (2021-2032)
- 4.2.3 Global Milk Coagulants Sales Market Share by Type (2021-2032)
- 4.3 Global Milk Coagulants Revenue by Type
- 4.3.1 Global Milk Coagulants Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Milk Coagulants Revenue by Type (2021-2032)
- 4.3.3 Global Milk Coagulants Revenue Market Share by Type (2021-2032)
5 Milk Coagulants Market by Application
- 5.1 Milk Coagulants Application Introduction
- 5.1.1 Cheese
- 5.1.2 Dessert
- 5.1.3 Yogurt
- 5.1.4 Others
- 5.2 Global Milk Coagulants Sales by Application
- 5.2.1 Global Milk Coagulants Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Milk Coagulants Sales by Application (2021-2032)
- 5.2.3 Global Milk Coagulants Sales Market Share by Application (2021-2032)
- 5.3 Global Milk Coagulants Revenue by Application
- 5.3.1 Global Milk Coagulants Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Milk Coagulants Revenue by Application (2021-2032)
- 5.3.3 Global Milk Coagulants Revenue Market Share by Application (2021-2032)
6 Global Milk Coagulants Sales by Region
- 6.1 Global Milk Coagulants Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Milk Coagulants Sales by Region (2021-2032)
- 6.2.1 Global Milk Coagulants Sales by Region (2021-2026)
- 6.2.2 Global Milk Coagulants Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Milk Coagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Milk Coagulants Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Milk Coagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Milk Coagulants Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Milk Coagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Milk Coagulants Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Milk Coagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Milk Coagulants Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Milk Coagulants Revenue by Region
- 7.1 Global Milk Coagulants Revenue by Region
- 7.1.1 Global Milk Coagulants Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Milk Coagulants Revenue by Region (2021-2026)
- 7.1.3 Global Milk Coagulants Revenue by Region (2027-2032)
- 7.1.4 Global Milk Coagulants Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Milk Coagulants Revenue (2021-2032)
- 7.2.2 North America Milk Coagulants Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Milk Coagulants Revenue (2021-2032)
- 7.3.2 Europe Milk Coagulants Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Milk Coagulants Revenue (2021-2032)
- 7.4.2 Asia-Pacific Milk Coagulants Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Milk Coagulants Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Milk Coagulants Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 DuPont
- 8.1.1 DuPont Company Information
- 8.1.2 DuPont Business Overview
- 8.1.3 DuPont Milk Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 DuPont Milk Coagulants Product Portfolio
- 8.1.5 DuPont Recent Developments
- 8.2 Chr. Hansen Holding A/S
- 8.2.1 Chr. Hansen Holding A/S Company Information
- 8.2.2 Chr. Hansen Holding A/S Business Overview
- 8.2.3 Chr. Hansen Holding A/S Milk Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Chr. Hansen Holding A/S Milk Coagulants Product Portfolio
- 8.2.5 Chr. Hansen Holding A/S Recent Developments
- 8.3 Enzyme Supplies Limited
- 8.3.1 Enzyme Supplies Limited Company Information
- 8.3.2 Enzyme Supplies Limited Business Overview
- 8.3.3 Enzyme Supplies Limited Milk Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Enzyme Supplies Limited Milk Coagulants Product Portfolio
- 8.3.5 Enzyme Supplies Limited Recent Developments
- 8.4 Koninklijke DSM N.V.
- 8.4.1 Koninklijke DSM N.V. Company Information
- 8.4.2 Koninklijke DSM N.V. Business Overview
- 8.4.3 Koninklijke DSM N.V. Milk Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Koninklijke DSM N.V. Milk Coagulants Product Portfolio
- 8.4.5 Koninklijke DSM N.V. Recent Developments
- 8.5 WalcoRen,
- 8.5.1 WalcoRen, Company Information
- 8.5.2 WalcoRen, Business Overview
- 8.5.3 WalcoRen, Milk Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 WalcoRen, Milk Coagulants Product Portfolio
- 8.5.5 WalcoRen, Recent Developments
- 8.6 Fonterra Co-operative Group
- 8.6.1 Fonterra Co-operative Group Company Information
- 8.6.2 Fonterra Co-operative Group Business Overview
- 8.6.3 Fonterra Co-operative Group Milk Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Fonterra Co-operative Group Milk Coagulants Product Portfolio
- 8.6.5 Fonterra Co-operative Group Recent Developments
- 8.7 Clarion Casein Ltd.
- 8.7.1 Clarion Casein Ltd. Company Information
- 8.7.2 Clarion Casein Ltd. Business Overview
- 8.7.3 Clarion Casein Ltd. Milk Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Clarion Casein Ltd. Milk Coagulants Product Portfolio
- 8.7.5 Clarion Casein Ltd. Recent Developments
- 8.8 Renco
- 8.8.1 Renco Company Information
- 8.8.2 Renco Business Overview
- 8.8.3 Renco Milk Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Renco Milk Coagulants Product Portfolio
- 8.8.5 Renco Recent Developments
- 8.9 Mahaan Foods Ltd
- 8.9.1 Mahaan Foods Ltd Company Information
- 8.9.2 Mahaan Foods Ltd Business Overview
- 8.9.3 Mahaan Foods Ltd Milk Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Mahaan Foods Ltd Milk Coagulants Product Portfolio
- 8.9.5 Mahaan Foods Ltd Recent Developments
- 8.10 AlindaVelco S.A.
- 8.10.1 AlindaVelco S.A. Company Information
- 8.10.2 AlindaVelco S.A. Business Overview
- 8.10.3 AlindaVelco S.A. Milk Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 AlindaVelco S.A. Milk Coagulants Product Portfolio
- 8.10.5 AlindaVelco S.A. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Milk Coagulants Value Chain Analysis
- 9.1.1 Milk Coagulants Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Milk Coagulants Production Mode & Process
- 9.2 Milk Coagulants Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Milk Coagulants Distributors
- 9.2.3 Milk Coagulants Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst